26 studies found for:    PARKINSON DISEASE 12
Show Display Options
RSS Create an RSS feed from your search for:
PARKINSON DISEASE 12
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed 12-Week, Double-Blind, Placeob-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
2 Completed 12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
Condition: Parkinson's Disease
Intervention: Drug: KW-6002 (istradefylline)
3 Recruiting A 12-week Randomized Study to Evaluate Oral Istradefylline in Subjects With Moderate to Severe Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Istradefylline 40 mg;   Drug: Istradefylline 20 mg;   Drug: Placebo
4 Completed Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist (12 Month Extension)
Condition: Parkinson's Disease
Interventions: Drug: Safinamide;   Drug: Placebo
5 Completed
Has Results
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
Condition: Parkinson Disease
Interventions: Drug: Pramipexole Immediate Release;   Drug: Pramipexole Extended Release
6 Completed
Has Results
A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients
Condition: Parkinson Disease
Interventions: Drug: Pramipexole;   Drug: Placebo
7 Unknown  Vitamin B6, B12, Folic Acid and Exercise in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Dietary Supplement: PD vitamin supplementation;   Other: PD exercise intervention;   Other: PD vitamin + exercise
8 Terminated Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Vitamin B12 Supplementation;   Dietary Supplement: Vitamin B12 supplement;   Dietary Supplement: vitamin B12
9 Completed Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Conditions: Dyskinesias;   Parkinson Disease;   Movement Disorders;   Parkinsonian Disorders
Interventions: Drug: AFQ056;   Drug: Placebo
10 Completed Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
Conditions: Parkinson Disease;   Idiopathic Parkinson Disease;   Idiopathic Parkinson's Disease
Interventions: Drug: preladenant;   Drug: Placebo to preladenant
11 Not yet recruiting Twelve Month Safety Efficacy and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: CVT-301
12 Completed Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
Conditions: Parkinson Disease;   Parkinson's Disease
Intervention: Drug: Ropinirole
13 Completed A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)
14 Withdrawn Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
Condition: Parkinson's Disease
Interventions: Drug: carbidopa/levodopa;   Drug: Carbidopa/Levodopa/Entacapone
15 Completed A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (Study P04938)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Placebo for Preladenant;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo for Rasagiline 1 mg capsule
16 Completed Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Dyskinesias;   Parkinson's Disease;   Severe Motor Fluctuations
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump
17 Completed A Study to Assess Safety and Tolerability of Oral AZD3241 in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: AZD3241 300 mg BID;   Drug: AZD3241 600 mg BID;   Drug: Placebo
18 Unknown  Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Condition: Parkinson's Disease
Intervention: Drug: Exenatide
19 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649  (Pitolisant)
20 Completed Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: BF2.649 (pitolisant)

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years